MRI-guided Neurosurgical Ablation Market Size, Share, Growth, Analysis Report

1. MRI-guided Neurosurgical Ablation Market is Growing at CAGR of 8% to Achieve USD 1.29 Billion by 2033 The worldwide MRI-guided neurosurgical ablation market (MRI ガイド下脳神経外科アブレーショ ン市場) is valued at approximately US$ 598.99 million in 2023. According to a recent study conducted by Fact.MR, the global demand for MRI-guided neurosurgical ablation systems is projected to grow at a compounded annual growth rate (CAGR) of 8%. By the year 2033, it is anticipated that the market will reach a valuation of around US$ 1.29 billion. One innovative and minimally-invasive neurosurgical technique used to treat brain tumors is MRI- guided laser ablation. This procedure employs laser technology to precisely target and eliminate or ablate the tumor. Compared to traditional open surgery, known as craniotomy, MRI-guided ablation offers several advantages, including reduced post-operative pain and a quicker recovery period. Download a Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8318 The Neurological Disorder Epidemic Neurological disorders encompass a wide range of conditions that affect the brain, spinal cord, and nervous system. These disorders can vary in severity, but many of them are debilitating and can significantly reduce a person's quality of life. Some of the most common neurological disorders include: 1.Brain Tumors: Brain tumors can be benign or malignant and may require surgical intervention. Accurate and precise treatment is critical to preserving brain function and improving patient outcomes. 2.Epilepsy: Epilepsy is a chronic neurological disorder characterized by recurrent seizures. For some patients, medication is ineffective, making surgical options like ablation necessary. 3.Parkinson's Disease: Parkinson's disease is a progressive neurological disorder that affects movement. Advanced therapies, including ablation procedures, can alleviate symptoms and improve patients' daily lives. 4.Essential Tremor: Essential tremor is a neurological condition that causes involuntary shaking. MR-guided ablation has shown promise in reducing tremors when medications fail. Market Growth Drivers Several factors are contributing to the rapid growth of the MRI-guided neurosurgical ablation market: 1.Increased Diagnosis Rates: Improved diagnostic tools and increased awareness of neurological disorders have led to earlier and more accurate diagnoses. This, in turn, drives the demand for effective treatment options like MRI-guided ablation. 2.Advancements in Technology: Ongoing innovations in MRI technology, such as real-time imaging and improved software, have made MRI-guided ablation procedures more accessible and effective for neurosurgeons. 3.Aging Population: The global population is aging, and neurological disorders often become more prevalent with age. This demographic shift is expected to contribute to the sustained growth of the market.

2. 4.Patient Demand: Patients are increasingly seeking minimally invasive and precise treatments that offer quicker recovery times and better outcomes. MRI-guided neurosurgical ablation meets these demands. 5.Investment and Research: Pharmaceutical companies and medical device manufacturers are investing heavily in research and development to enhance the capabilities of MRI-guided ablation systems. Competitive Landscape In the pursuit of gaining a competitive edge, businesses are increasingly focusing on research and development to craft technologically advanced products, with a primary goal of enhancing product quality standards. A notable example of this commitment to innovation is exemplified by MRI Interventions, Inc., a prominent player in the neurosurgical industry. In January 2019, they received approval from the U.S. FDA for their ClearPoint PURSUIT Neuro Aspiration system. Developed in collaboration with the Mayo Clinic, this system is designed for the precise aspiration of abscesses, cerebral spinal fluid, clots, and cystic tumors. Similarly, in April 2018, Medtronic introduced the Visualase MRI-Guided Laser Ablation System to the European market. This minimally-invasive laser therapy is tailored for the treatment of brain- related issues, offering precise targeting and treatment of specific undesirable tissue areas. Furthermore, companies are actively engaging in strategic maneuvers like mergers, collaborations, and acquisitions to broaden their product portfolios, enhance manufacturing capabilities, optimize supply chain management, and gain a broader spectrum of competitive advantages. A prime example of this strategic approach is demonstrated by Insightec, which secured a substantial investment of US$ 150 million in March 2020. This funding is earmarked for the development of incisionless surgical equipment utilized in the treatment of tremors in individuals with tremor-dominant Parkinson's disease (PD) who are unresponsive to traditional medications. In another development, Medtronic introduced Accurian, a cutting-edge radiofrequency ablation technology, in February 2019. This innovative system features state-of-the-art hardware, advanced temperature control software, and a quad-core processor, all meticulously designed to enhance the efficiency of standard, pulsed, and enhanced procedures. MRI-guided Neurosurgical Ablation Industry Research Segments  By Product : oRF Ablation Systems oLaser Ablation Systems oFocused Ultrasound Systems oAccessories By End User : oHospitals oAmbulatory Surgical Centers oClinics oResearch Laboratories By Region : oNorth America  

3. oLatin America oEurope oEast Asia oSouth Asia & Oceania oMEA The rising incidence of neurological disorders is a significant driver behind the expanding MRI-guided neurosurgical ablation market. As the global healthcare community continues to grapple with the challenges posed by these complex conditions, innovative technologies like MRI-guided ablation offer hope for improved patient outcomes and a better quality of life. With ongoing research and technological advancements, the future of neurosurgery appears promising, promising new opportunities for patients and medical professionals alike. Contact: US Sales Office 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583, +353-1-4434-232 Email: sales@factmr.com